Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,020.00    -52.00 (-2.51%)
Bid:
2,008.00
Ask:
2,016.00
Spread: 8.00 (0.398%)
Market Cap: £1.34b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Director/PDMR Shareholding

10 Sep 2009 16:37

RNS Number : 8819Y
Genus PLC
10 September 2009
 



10 September 2009

FOR IMMEDIATE RELEASE 

Genus plc

('Genus' or 'the Company')

Director/PDMR Shareholding

Of 119,386 ordinary shares of 10 pence each in the Company ('Ordinary Shares') that vested today in favour of Richard Wood, Chief Executive, under the Company's Performance Share Plan (the 'Plan'), 60,290 Ordinary Shares are being retained by Richard Wood as part of his shareholding in the Company. 49,096 Ordinary Shares were today sold on behalf of Richard Wood at a price of 621.39 pence per Ordinary Share to satisfy income tax and national insurance contributions payable by Richard Wood as a result of today's vesting and a further 10,000 Ordinary Shares were also sold today at a price of 621.39 pence per Ordinary Share on behalf of Richard Wood.

Richard Wood's direct shareholding in the Company now stands at 120,595 Ordinary Shares which represent 0.203% of the issued share capital of the Company which is currently 59,529,534 Ordinary Shares. In addition, he remains the beneficial owner of 223,710 conditional shares and nil-cost options under the Plan.

Of 68,220 Ordinary Shares that vested today in favour of Ian Biggs, Chief Operating Officer for the Americas, under the Plan, 26,777 Ordinary Shares are being retained by Ian Biggs as part of his shareholding in the Company. 28,055 Ordinary Shares were today sold on behalf of Ian Biggs at a price of 621.39 pence per Ordinary Share to satisfy income tax and national insurance contributions payable by Ian Biggs as a result of today's vesting and a further 13,388 Ordinary Shares were also sold today at a price of 621.39 pence per Ordinary Share on behalf of Ian Biggs.

Ian Biggs' direct shareholding in the Company now stands at 30,152 Ordinary Shares which represent 0.051of the issued share capital of the Company which is currently 59,529,534 Ordinary Shares. In addition, he remains the beneficial owner of 85,932 conditional shares and nil-cost options under the Plan.

Of 42,700 Ordinary Shares that vested today in favour of Thomas Philip Acton, Chief Operating Officer for Europe and The Far East, under the Plan, 16,760 Ordinary Shares are being retained by Thomas Philip Acton as part of his shareholding in the Company. 17,560 Ordinary Shares were today sold on behalf of Thomas Philip Acton at a price of 621.39 pence per Ordinary Share to satisfy income tax and national insurance contributions payable by Thomas Philip Acton as a result of today's vesting and a further 8,380 Ordinary Shares were also sold today at a price of 621.39 pence per Ordinary Share on behalf of Thomas Philip Acton.

Thomas Philip Acton's direct shareholding in the Company now stands at 37,864 Ordinary Shares which represent 0.064% of the issued share capital of the Company which is currently 59,529,534 Ordinary Shares. In addition, he remains the beneficial owner of 78,627 conditional shares and nil-cost options under the Plan.

Of 42,700 Ordinary Shares that vested today in favour of Steve Amies, Chief Operating Officer for Global Research & Product Development, under the Plan, 16,760 Ordinary Shares are being retained by Steve Amies as part of his shareholding in the Company. 17,560 Ordinary Shares were today sold on behalf of Steve Amies at a price of 621.39 pence per Ordinary Share to satisfy income tax and national insurance contributions payable by Steve Amies as a result of today's vesting and a further 8,380 Ordinary Shares were also sold today at a price of 621.39 pence per Ordinary Share on behalf of Steve Amies.

Steve Amies' direct shareholding in the Company now stands at 16,760 Ordinary Shares which represent 0.028% of the issued share capital of the Company which is currently 59,529,534 Ordinary Shares. In addition, he remains the beneficial owner of 58,623 conditional shares and nil-cost options under the Plan.

 

For further information please contact:

 

Ian Farrelly Tel: 01256 345996

Group Company Secretary & General Counsel

Genus plc

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSUROVRKBRKAAR
Date   Source Headline
8th Mar 20223:47 pmRNSNotification of Major Holdings
8th Mar 20221:13 pmRNSNotification of Major Holdings
24th Feb 20227:00 amRNSCollaboration between PIC and Olymel LP in Canada
24th Feb 20227:00 amRNSInterim Results
1st Feb 20224:57 pmRNSBlock listing Interim Review
4th Jan 20229:47 amRNSTotal Voting Rights
26th Nov 202110:18 amRNSDisclosure of Rights Attached to Equity Shares
24th Nov 20215:51 pmRNSDirector/PDMR Shareholding
24th Nov 20212:47 pmRNSResult of AGM
24th Nov 20212:30 pmRNSDirector/PDMR Shareholding
24th Nov 20217:00 amRNSAGM Trading Update
10th Nov 20212:28 pmRNSNotification of Major Holdings
15th Oct 20217:00 amRNSAnnual Report and Annual General Meeting
13th Oct 20215:56 pmRNSDirector/PDMR Shareholding
1st Oct 20213:58 pmRNSTotal Voting Rights
30th Sep 20219:59 amRNSDirector Declaration
29th Sep 20212:59 pmRNSNotification of Major Holdings
15th Sep 20214:45 pmRNSDirector/PDMR Shareholding
14th Sep 20214:32 pmRNSDirector/PDMR Shareholding
9th Sep 20217:00 amRNSPreliminary Results
1st Sep 20212:05 pmRNSTotal Voting Rights
2nd Aug 20214:00 pmRNSBlock listing Interim Review
2nd Aug 202110:09 amRNSTotal Voting Rights
1st Jul 20214:39 pmRNSTotal Voting Rights
28th Jun 20215:00 pmRNSPIC AND SERGAL ENTER INTO STRATEGIC RELATIONSHIP
22nd Jun 20217:00 amRNSCapital Markets Event & PRRSv Programme Update
14th Jun 20213:01 pmRNSNotification of Major Holdings
7th Jun 202110:42 amRNSApplication For Additional Listing
4th Jun 20214:38 pmRNSNotification of Major Holdings
17th May 20211:23 pmRNSNotification of Major Holdings
13th May 202110:50 amRNSDirector/PDMR Shareholding
9th Apr 20214:10 pmRNSDirector/PDMR Shareholding
6th Apr 20216:00 pmRNSDirector/PDMR Shareholding
1st Apr 20215:49 pmRNSTotal Voting Rights
31st Mar 20212:59 pmRNSDirector/PDMR Shareholding
22nd Mar 20217:00 amRNSBoard Changes
19th Mar 202112:20 pmRNSDirector/PDMR Shareholding
9th Mar 20215:41 pmRNSNotification of Major Holdings
3rd Mar 20215:19 pmRNSDirector/PDMR Shareholding
26th Feb 202112:39 pmRNSDirector/PDMR Shareholding
25th Feb 20217:00 amRNSInterim Results
1st Feb 202111:08 amRNSBlock listing Interim Review
1st Feb 202111:08 amRNSTotal Voting Rights
18th Jan 20217:00 amRNSTrading Update
2nd Dec 20205:44 pmRNSDirector/PDMR Shareholding
25th Nov 20201:13 pmRNSResult of AGM
25th Nov 20207:00 amRNSAGM Trading Update - Strong Performance Continues
11th Nov 20201:03 pmRNSNOTIFICATION OF MAJOR HOLDINGS
16th Oct 20208:00 amRNSAnnual Report and Annual General Meeting
1st Oct 20203:45 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.